Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 5/20 | 0.46 |
| ▸ | HSD17B2 | P37059 | 5/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.46 |
| ▸ | CYP2B6 | P20813 | 4/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 12/20 | 0.45 |
| ▸ | ESR1 | P03372 | 11/20 | 0.45 |
| ▸ | ABL1 | P00519 | 2/20 | 0.40 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.40 |
| ▸ | BCR | P11274 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13871469 | 0.99 | HSD17B1 (0.47) | HSD17B1HSD17B2CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL13871471 | 0.99 | HSD17B1 (0.47) | HSD17B1HSD17B2CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL13871476 | 0.89 | HSD17B1 (0.54) | HSD17B1HSD17B2CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL13871466 | 0.89 | HSD17B1 (0.54) | HSD17B1HSD17B2CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL13871477 | 0.86 | HSD17B1 (0.56) | HSD17B1HSD17B2CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL13871465 | 0.85 | HSD17B1 (0.50) | HSD17B1HSD17B2CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL20169571 | 0.80 | ALOX5 (0.50) | HSD17B1HSD17B2CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL12054411 | 0.78 | CYP1A2 (0.58) | CYP1A2CYP3A4ESR2ESR1ABL1 | |
| SCHEMBL20356051 | 0.78 | CYP1A2 (0.58) | CYP1A2CYP3A4ESR2ESR1ABL1 | |
| SCHEMBL12054413 | 0.78 | CYP1A2 (0.58) | CYP1A2CYP3A4ESR2ESR1ABL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9475761-B2 | Method for producing cyanogen-halide, cyanate ester compound and method for producing the same, and resin composition | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2016-10-25 | — | — | US | disclosed |
| US-9475761-B2 | Method for producing cyanogen-halide, cyanate ester compound and method for producing the same, and resin composition | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2016-10-25 | — | — | US | disclosed |
| US-20150299110-A1 | METHOD FOR PRODUCING CYANOGEN-HALIDE, CYANATE ESTER COMPOUND AND METHOD FOR PRODUCING THE SAME, AND RESIN COMPOSITION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2015-10-22 | — | — | US | disclosed |
| US-20150299110-A1 | METHOD FOR PRODUCING CYANOGEN-HALIDE, CYANATE ESTER COMPOUND AND METHOD FOR PRODUCING THE SAME, AND RESIN COMPOSITION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2015-10-22 | — | — | US | disclosed |
| WO-2014065422-A9 | CYANOGEN-HALIDE PRODUCTION METHOD, CYANATE ESTER COMPOUND AND PRODUCTION METHOD THEREFOR, AND RESIN COMPOSITION | 三菱瓦斯化学株式会社 (JP) | 2014-07-10 | — | — | WO | disclosed |
| US-8729192-B2 | Epoxy resin composition, cured article thereof, novel epoxy resin, novel phenol resin and semiconductor-encapsulating material | DIC CORPORATION (JP) | 2014-05-20 | — | — | US | disclosed |
| US-8729192-B2 | Epoxy resin composition, cured article thereof, novel epoxy resin, novel phenol resin and semiconductor-encapsulating material | DIC CORPORATION (JP) | 2014-05-20 | — | — | US | disclosed |
| WO-2014065422-A1 | CYANOGEN-HALIDE PRODUCTION METHOD, CYANATE ESTER COMPOUND AND PRODUCTION METHOD THEREFOR, AND RESIN COMPOSITION | 三菱瓦斯化学株式会社 (JP) | 2014-05-01 | — | — | WO | disclosed |
| US-20090099303-A1 | EPOXY RESIN COMPOSITION, CURED ARTICLE THEREOF, NOVEL EPOXY RESIN, NOVEL PHENOL RESIN AND SEMICONDUCTOR-ENCAPSULATING MATERIAL | DIC CORPORATION (JP) | 2009-04-16 | — | — | US | disclosed |
| US-20090099303-A1 | EPOXY RESIN COMPOSITION, CURED ARTICLE THEREOF, NOVEL EPOXY RESIN, NOVEL PHENOL RESIN AND SEMICONDUCTOR-ENCAPSULATING MATERIAL | DIC CORPORATION (JP) | 2009-04-16 | — | — | US | disclosed |
| US-20090088535-A1 | METHOD OF PRODUCING PHENOL RESIN AND METHOD OF PRODUCING EPOXY RESIN | DIC CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
| US-20090088535-A1 | METHOD OF PRODUCING PHENOL RESIN AND METHOD OF PRODUCING EPOXY RESIN | DIC CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150299110-A1 | METHOD FOR PRODUCING CYANOGEN-HALIDE, CYANATE ESTER COMPOUND AND METHOD FOR PRODUCING THE SAME, AND RESIN COMPOSITION | MB, CBR3, CRYAA | HSD17B1 3627/4885HSD17B2 3682/4885CYP1A2 1055/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.